title: A rationale for setting target plasma lipid levels to reverse atherosclerosis.
authors.affiliation: Rogosin Institute, New York, New York.
authors.forename: T S
authors.initials: TS
authors.lastname: Parker
authors.forename: S D
authors.initials: SD
authors.lastname: Saal
authors.forename: B R
authors.initials: BR
authors.lastname: Gordon
authors.forename: T I
authors.initials: TI
authors.lastname: Tyberg
authors.forename: D M
authors.initials: DM
authors.lastname: Levine
authors.forename: A L
authors.initials: AL
authors.lastname: Rubin
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000097:blood* / Q000628:therapy; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003131:Combined Modality Therapy; D006801:Humans; D008055:Lipids / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D010956:Plasmapheresis
chemical_list: D008076:Cholesterol, HDL; D008055:Lipids; D008077:Lipoproteins, LDL; D002784:Cholesterol